Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study
Xiang Li(PLA 306 Hospital), Jianping Weng(University of Science and Technology of China), Jun Zhu(Population Health Research Institute), Linong Ji(Peking University), Bingying Shi(First Affiliated Hospital of Xi'an Jiaotong University), Zhongyan Shan(First Hospital of China Medical University), Longyi Zeng(Sun Yat-sen University), Zhiguang Zhou(Central South University), Kun Feng(Heilongjiang Provincial Hospital), Zhangrong Xu(PLA 306 Hospital), Dalong Zhu(National Clinical Research Center for Digestive Diseases), Limin Chen(Tianjin Infectious Diseases Hospital), Yushan Xu(Kunming Medical University), Weiping Jia(NovaBay Pharmaceuticals (United States)), Jing Liu(Fujian Medical University), Lixin Guo(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 59
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
|Pharmacological Reviews|2021|1.1k